Red Arrow Therapeutics, Inc. (“Red Arrow”) is an innovative Japanese biotech company that aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity.
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.04.2024 | Seed | $4.5M | - |
Mentions in press and media 8
| Date | Title | Description |
| 23.04.2024 | Osaka University Venture Capital Co., Ltd. Made an investment in “Red Arrow Therapeutics, Inc.” | Osaka University Venture Capital Co., Ltd.
Made an investment in “Red Arrow Therapeutics, Inc.”
……
[Image: https://prtimes.jp/i/51435/63/resize/d51435-63-8dfec0bfb85abe9e4b32-0.png&s3=51435-63-99655323d9e5e3d50ba083cecbc7ab2f-2000×684.p... |
| 23.04.2024 | Osaka University Venture Capital Co., Ltd. Made an investment in “Red Arrow Therapeutics, Inc.” | - |
| 23.04.2024 | Red Arrow Therapeutics Nabs $4.5M |
BOSTON, MA, Red Arrow Therapeutics has closed a $4.5 million Seed Extension round.
>> Click here for more funding data on Red Arrow Therapeutics
>> To export Red Arrow Therapeutics funding data to PDF and Excel, click here
Red ... |
| 23.04.2024 | Keio Innovation Initiative (KII) KII invests in Red Arrow Therapeutics, which develops next-generation anticancer drugs using nanotechnology | - |
| 23.04.2024 | Keio Innovation Initiative (KII) KII invests in Red Arrow Therapeutics, which develops next-generation anticancer drugs using nanotechnology | Keio Innovation Initiative (KII)
KII invests in Red Arrow Therapeutics, which develops next-generation anticancer drugs using nanotechnology
Promoting the development and manufacturing of anticancer drugs using innovative drug delivery tech... |
| 23.04.2024 | Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round | BOSTON, April 23, 2024 /PRNewswire/ -- Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
Participants of this round are:
Beyond Next Ventures Inc.
The University o... |
| 23.04.2024 | Red Arrow Therapeutics Closes $4.5M Seed Extension Funding | Red Arrow Therapeutics Inc., a Boston, MA-based developer of pH-sensing nanomedicine drug delivery technologies, closed a $4.5M Seed Extension round.
Participants of this round were:
Beyond Next Ventures Inc.
The University of Tokyo Edge Ca... |
| - | Red Arrow Therapeutics | “HOME | Red Arrow Theraputic” |
Reviews 0
